Literature DB >> 21914082

Effector T cells immune reactivity among patients with acute hepatitis E.

M M Husain1, R Aggarwal, D Kumar, S Jameel, S Naik.   

Abstract

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis in several developing countries. Information on cellular immune responses during acute hepatitis E is limited. We therefore studied peripheral blood mononuclear cells (PBMCs) from patients with acute hepatitis E and healthy adult subjects who lacked anti-HEV antibodies for enumeration of various T-cell subsets using flow cytometry and to assess HEV-specific T effector cell responses using interferon-gamma ELISPOT assays. The patients showed increased numbers of CD8(+) cells and CD4(+) CD8(+) cells compared with healthy controls. In addition, the proportion of PBMCs that produced interferon-gamma in response to recombinant HEV open reading frame (ORF) 2 and ORF 3 proteins were found to be higher in patients than in healthy controls. Using pools of 15-mer overlapping peptides corresponding to these recombinant proteins, the immunodominant regions in these proteins for interferon-gamma-producing cells were mapped to regions corresponding to amino acids 181-249 and 301-489 of HEV ORF2 protein. These data provide evidence for the activation of effector T cells during acute hepatitis E. These responses may play a role in viral clearance from the host in patients with HEV infection.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914082     DOI: 10.1111/j.1365-2893.2011.01489.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

Review 1.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

2.  Changes in gene expression in liver tissue from patients with fulminant hepatitis E.

Authors:  Anshu Naik; Amit Goel; Vinita Agrawal; Aditya N Sarangi; Nanda Chhavi; Vineeta Singh; Shahid Jameel; Rakesh Aggarwal
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 3.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

4.  Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.

Authors:  Anuradha S Tripathy; Rumki Das; Sanjay B Rathod; Vidya A Arankalle
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

5.  ORF3 as a sensitive and specific diagnostic index for hepatitis E.

Authors:  Lijuan Li; Min Liu; Chengrui Geng; Yunmei Zou; Tong Jiao
Journal:  Exp Ther Med       Date:  2017-04-13       Impact factor: 2.447

6.  Chronic Hepatitis E is associated with cholangitis.

Authors:  Andrea Beer; Heidemarie Holzmann; Sven Pischke; Patrick Behrendt; Fritz Wrba; Jerome Schlue; Uta Drebber; Barbara Neudert; Emina Halilbasic; Hans Kreipe; Ansgar Lohse; Martina Sterneck; Heiner Wedemeyer; Michael Manns; Hans P Dienes
Journal:  Liver Int       Date:  2019-06-17       Impact factor: 5.828

7.  Serological investigation for hepatitis E virus infection in the patients with chronic maintenance hemodialysis from southwest of Iran.

Authors:  Omid R Zekavat; Alireza Makarem; Mohammad Y Karami; Aida Amanat; Maesoomeh Mohandes; Mojtaba Habibagahi
Journal:  Asian J Transfus Sci       Date:  2013-01

8.  Cytokine Profiles and Cell Proliferation Responses to Truncated ORF2 Protein in Iranian Patients Recovered from Hepatitis E Infection.

Authors:  Reza Taherkhani; Fatemeh Farshadpour; Manoochehr Makvandi; Hamid Rajabi Memari; Ali Reza Samarbafzadeh; Nasrin Sharifi; Behrouz Naeimi; Saeed Tajbakhsh; Samad Akbarzadeh
Journal:  J Trop Med       Date:  2015-09-15

9.  Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection.

Authors:  Alireza Rafiei; Abolghasem Ajami; Araz Mohammad Mirabi; Mohammad Jafar Saffar; Omolbanin Amjadi; Mohammad Reza Haghshenas; Farshideh Abedian; Pouya Khaje-Enayati
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

Review 10.  Hepatitis E Pathogenesis.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Sabine Chapuy-Regaud; Nassim Kamar; Jacques Izopet
Journal:  Viruses       Date:  2016-08-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.